Equi-Jec 7This page contains information on Equi-Jec 7 for veterinary use.
The information provided typically includes the following:
- Equi-Jec 7 Indications
- Warnings and cautions for Equi-Jec 7
- Direction and dosage information for Equi-Jec 7
Equi-Jec 7This treatment applies to the following species:
Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Vaccine
Eastern, Western, & Venezuelan, Killed Virus
For Use In Animals Only
Equi-Jec 7 Indications
For vaccination of healthy horses 4 months of age or older as an aid in the prevention of disease caused by eastern, western, and venezuelan encephalomyelitis and tetanus; as an aid in the reduction of respiratory disease caused by equine influenza virus (EIV) (product contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Eurasian Newmarket/2/93 (NM 2/93) EIV strains), and equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4); as an aid in the reduction of severity of clinical disease, and an aid in the prevention of viremia and mortality caused by west nile virus (WNV). Safe for use in pregnant mares. The duration of immunity (DOI) is at least 6 months for OH/03 and at least 12 months for WNV.
Directions and dosage: Shake well before use. Using aseptic technique, vaccinate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
PrecautionsStore at 35-46°F (2-8°C). Do not freeze. Do not vaccinate within 21 days before slaughter. Do not mix with other products. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.
Preservatives: Gentamicin and Amphotericin B.
Equi-Jec® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.
© 2017 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.
US Patent Nos. 7,309,598; 8,697,089; 8,821,889; and 9,517,259.
US Patent Nos. 7,572,620; 8,535,685; 8,784,838; 9,180,181; and 9,492,530, used under license.
Manufactured/Distributed By: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
1 Dose/1 mL
3239 SATELLITE BLVD., DULUTH, GA, 30096
|Every effort has been made to ensure the accuracy of the Equi-Jec 7 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2020 Animalytix LLC. Updated: 2020-10-21